Notably, one tumor aligned with high calibrated score to another novel uncharacterized methylation class “Adult-type diffuse high-grade glioma, IDH-wildtype, subtype E”, and two others did not match with any reference classes in the current version of the classifier. The gene discussed is IDH2; the disease is central nervous system cancer.